Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 3/2015

01-09-2015 | Historical and Literary

The Essay on waters and other medical writings of Charles Lucas

Author: S. J. Murphy

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2015

Login to get access

Abstract

In recent years, more attention has been given to Charles Lucas’s medical career, in its own way just as interesting and important as his better-known political campaigns. Lucas’s first concentrated period of medical activity was in the 1730s, when he had qualified as an apothecary, the second in the 1750s, following his flight from Ireland and achievement of qualifications in medicine. Having been prominently involved in the campaign which led to the 1735 drugs regulation act, in 1741 Lucas published a pamphlet, Pharmacomastix, which detailed abuses common in the apothecary’s trade and pressed for more radical controls. His most substantial medical work, An Essay on Waters, was published in London in 1756, being devoted to analysis of European spas and the promotion of hydrotherapy. Lucas was able to return to Ireland in 1761 and was elected MP for Dublin city. While politics occupied most of his time until his death in 1771, Lucas maintained his interest in matters medical, securing the passage of another drugs regulation act in 1761, which remarkably is still on the Irish statute book.
Literature
2.
go back to reference Lucas C (1750) A Critical Review of the Liberties of British Subjects. 2nd edn. Printed for R. Watkins London, p 370 Lucas C (1750) A Critical Review of the Liberties of British Subjects. 2nd edn. Printed for R. Watkins London, p 370
3.
go back to reference Lucas C (1741) Pharmacomastix: or, the office, use and abuse of apothecaries explained. Printed by S. Powell, for Abraham Bradley, Dublin Lucas C (1741) Pharmacomastix: or, the office, use and abuse of apothecaries explained. Printed by S. Powell, for Abraham Bradley, Dublin
4.
go back to reference Lucas C (1752) Dissertatio medica inauguralis de gangraena et sphacelo. George Wishoff, Leyden Lucas C (1752) Dissertatio medica inauguralis de gangraena et sphacelo. George Wishoff, Leyden
9.
go back to reference Lucas C (1757) Letters of Dr Lucas and Dr Oliver occasioned by a physical confederacy discovered in Bath. Printed for R Griffiths, London Lucas C (1757) Letters of Dr Lucas and Dr Oliver occasioned by a physical confederacy discovered in Bath. Printed for R Griffiths, London
10.
go back to reference Lucas C (1757) Dr Rutty’s methodical synopsis of mineral waters. Printed for A Millar, London Lucas C (1757) Dr Rutty’s methodical synopsis of mineral waters. Printed for A Millar, London
11.
go back to reference Lucas C (1756) letter to Lord Boyle, 26 July 1756. Public Record Office of Northern Ireland D2707/A/2/11/1 Lucas C (1756) letter to Lord Boyle, 26 July 1756. Public Record Office of Northern Ireland D2707/A/2/11/1
Metadata
Title
The Essay on waters and other medical writings of Charles Lucas
Author
S. J. Murphy
Publication date
01-09-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-015-1256-y

Other articles of this Issue 3/2015

Irish Journal of Medical Science (1971 -) 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine